When was MindBio Therapeutics founded?

MindBio Therapeutics was founded in 2021 and raised its 1st funding round 3 years after it was founded.

Where is MindBio Therapeutics located?

MindBio Therapeutics is headquartered in Melbourne, Australia.

How many employees does MindBio Therapeutics have?

As of Aug 31, 2026, the latest employee count at MindBio Therapeutics is 5.

Is MindBio Therapeutics a funded company?

MindBio Therapeutics is a funded company, having raised an undisclosed amount across 6 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on Dec 09, 2024.

When was the latest funding round of MindBio Therapeutics?

MindBio Therapeutics' latest funding was a $***** Post IPO round on Apr 01, 2026, with participation from 0 investor.

Where does MindBio Therapeutics rank among its competitors?

MindBio Therapeutics ranks 5th amongst 100 active competitors, of which 7 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was MindBio Therapeutics, which secured an undisclosed amount in Apr, 2026.

Who are the top competitors of MindBio Therapeutics?

MindBio Therapeutics' top competitors include Celerion, HMR London and Altasciences. Among them, MindBio Therapeutics secured the most recent funding round in April, 2026.

MindBio Therapeutics - 2026 Company Profile, Funding & Competitors

MindBio Therapeutics is a public company based in Melbourne (Australia), founded in 2021. It operates as a Provider of phase I & II clinical trial services for mental health diseases. MindBio Therapeutics has raised an undisclosed amount in funding. The company has 100 active competitors, including 7 funded and 23 that have exited. Its top competitors include companies like Celerion, HMR London and Altasciences.

Company Details

Website: mindbiotherapeutics.com
Social
Email ID: *****@mindtherapeutics.com.au

Key Metrics

Founded Year

2021

Location

Melbourne, Australia

Stage

Public

Latest Funding Round

Post IPO, Apr 01, 2026, $*****

Investors

Blackhawk Growth Corp & 1 more

Ranked

5^th among 100 active competitors

Employee Count

5 as on Aug 31, 2026

Similar Companies

Celerion & 119 more

Exit Details

Public

View MindBio Therapeutics' full profile

MindBio Therapeutics got listed on May 05, 2023.

Click here to take a look at MindBio Therapeutics's IPO in detail

MindBio Therapeutics has raised funding over 6 rounds. Its first funding round was on Dec 09, 2024. MindBio Therapeutics has 2 institutional investors.

Here is the list of recent funding rounds of MindBio Therapeutics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 01, 2026	4899946	Post IPO	2913597	7253005	5167395	4260037
May 19, 2025	8243312	Post IPO	7544621	6535120	1648749	3192262
Apr 23, 2025	1974400	Post IPO	1788304	1340215	7844451	6683661

Access funding benchmarks and valuations. Sign up today!

View details of MindBio Therapeutics's funding rounds and investors

MindBio Therapeutics' employee count trend

MindBio Therapeutics has 5 employees as of Aug 26. Here is MindBio Therapeutics's employee count trend over the years:

Employee count trend for MindBio Therapeutics

Uncover MindBio Therapeutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MindBio Therapeutics include Celerion, HMR London and Altasciences. Here is the list of Top 10 competitors of MindBio Therapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Celerion 2010, Lincoln (United States), Acquired	Translational medicine experts accelerating drug development for global patient impact	-	Bain Capital Ventures, H.I.G. Private Equity ... & 7 others	51/100
2nd	HMR London 1993, London (United Kingdom), Acquired	Provider of early phase clinical research services for drug development	-	EIC Fund, Europa	51/100
3rd	Altasciences 2015, Laval (Canada), Acquired	Early phase CRO	-	Apollo Investment Corporation, Signet Healthcare Partners ... & 1 others	50/100
4th	BioPharma Services 2006, Toronto (Canada), Acquired	Provider of early stage clinical trial services	-	-	48/100
5th	MindBio Therapeutics 2021, Melbourne (Australia), Public	Provider of phase I & II clinical trial services for mental health diseases	-	Blackhawk Growth Corp, Hardenbrook Group	44/100
6th	Avance Clinical 2018, Thebarton (Australia), Late Stage	Provider of clinical development services	-	Riverside, Genesis Capital	43/100
7th	Aditum Bio 2019, Cambridge (United States), Unfunded	CRO focused on clinical trial on phase II studies	-	-	42/100
8th	iCardiac Technologies 2006, Rochester (United States), Acquired	Company offering core laboratory services mainly for cardiac safety testing and respiratory diseases	$4M	Stonehenge Growth Equity Partners, Norwest ... & 4 others	41/100
9th	Unravel Biosciences 2020, Boston (United States), Seed	CRO offering early stage clinical development of drugs	$500K	BoxOne Ventures, Beresford Ventures	40/100
10th	Ventura Biomed 2021, Germany, Unfunded	CRO offering early stage drug development services	-	-	40/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on MindBio Therapeutics's competitors? Click here to see the top ones

MindBio Therapeutics has made no investments or acquisitions yet.

Here is the latest report on MindBio Therapeutics's sector:

Free

Biopharma Outsourcing - Sector Report

Edition: July, 2026 (67 Pages)

View all reports related to MindBio Therapeutics

Media has covered MindBio Therapeutics for a total of 13 events in the last 1 year, 9 of them have been about company updates and 1 about people movement.